Enliven Therapeutics

ELVN

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-104.55M

EBITDA$-88.16M

EBIT$-88.79M

Pre-tax Income$-103.69M

Net Income$-89.02M

Cash Equivalent$117.75M

Total Debt$0

Book Value$305.22M

Book Value Per Share6.62

Return on Equity (ROE)-28.73%

Return on Assets (ROA)-27.33%

Return on Invested Capital (ROI)-28.73%

Net Profit Marginundefined

Current Ratio19.99

Quick Ratio19.70

Long-Term Debt / Equity0.08